Viperin

Last updated
RSAD2
Viperin-CTP-SAH.png
Identifiers
Aliases RSAD2 , 2510004L01Rik, cig33, cig5, vig1, radical S-adenosyl methionine domain containing 2, Viperin Protein, Viperin
External IDs OMIM: 607810; MGI: 1929628; HomoloGene: 10969; GeneCards: RSAD2; OMA:RSAD2 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

91543

58185

Ensembl

ENSG00000134321

ENSMUSG00000020641

UniProt

Q8WXG1

Q8CBB9

RefSeq (mRNA)

NM_080657

NM_021384

RefSeq (protein)

NP_542388

NP_067359

Location (UCSC) Chr 2: 6.87 – 6.9 Mb Chr 12: 26.49 – 26.51 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Radical S-adenosyl methionine domain-containing protein 2 is a protein that in humans is encoded by the RSAD2 gene. RSAD2 is a multifunctional protein in viral processes that is an interferon stimulated gene. [5] It has been reported that viperin could be induced by either IFN-dependent or IFN-independent pathways and certain viruses may use viperin to increase their infectivity. [6] [7]

Contents

The protein was previously called virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (viperin). The name viperin has been rectified due to inappropriate use of it to describe homologous prokaryotic enzymes producing nucleotide analogues. [8] The enzymes across all domains of life are renamed SAM-dependent nucleotide dehydratase (SAND) using NC-IUBMB recommendations. [8]

Function

Viperin is an interferon-stimulated gene whose expression inhibits many DNA and RNA viruses including CHIKV, HCMV, HCV, DENV, WNV, SINV, influenza, and HIV. [6] Initially identified as an IFN-γ induced antiviral protein in human cytomegalovirus (HCMV) infected macrophages, it was reported that viperin could be induced by HCMV glycoprotein B in fibroblasts, but inhibits HCMV viral infection and down-regulates viral structural proteins. The reason why virus protein would induce viperin against itself is still not clear; however, the viral induced redistribution of viperin may reflect the mechanism of virus evading its antiviral activities. [9] Viperin may also be induced and interact with HCMV viral proteins and relocate to mitochondria in HCMV viral infected cells to enhance viral infectivity by disrupting cellular metabolism. [10]

Viperin is a radical SAM enzyme which is capable of producing the chain terminator ddhCTP (3ʹ-deoxy-3′,4ʹdidehydro-CTP), which inhibits the viral RNA dependent RNA polymerase (RdRp). [11] ddhCTP also appears to abolish metabolism of amino acids and mitochondrial respiration. [12]

In the inhibition of influenza virus budding and release, viperin is suggested to disrupt the lipid rafts on the cell's plasma membrane by binding to and decreasing the enzyme activities of farnesyl diphosphate synthase (FPPS), an essential enzyme in isoprenoid biosynthesis pathway. [13] Viperin was suggested to inhibit the viral replication of HCV via its interaction with host hVAP-33 and viral NS5A and disrupting the formation of the replication complex. [14]

Structure

Human viperin is a single polypeptide of 361 amino acids with a predicted molecular weight of 42 kDa. The N-terminal 42 amino acids of viperin forms amphipathic alpha-helix, which is relatively less conserved in different species and has a minor effect on the antiviral activity of viperin. The N-terminal domain of viperin is required for its localization to the ER and lipid droplets. [15] Amino acids 77-209 of viperin constitute the radical S-adenosyl methionine (SAM) domain, containing four conserved motifs. Motif 1 has three conserved cysteine residues, CxxCxxC, which is the Fe-S binding motif and also essential for antiviral activity. [10] The C-terminal 218-361 amino acids of viperin are highly conserved in different species and essential for viperin dimerization. The C-terminal tail appears to be critical for the antiviral activities against HCV since a C-terminal flag tagged of viperin lost its antiviral activity. [16]

When viperin is bound to SAM and Cytidine triphosphate (CTP) or uridine triphosphate (UTP) is used as a substrate, different kinetic parameters are achieved. [17] It is predicted that the CTP substrate binds much more tightly with viperin because of the low Km value of the substrate. However, the overall structure of both UTP- and CTP-bound compounds are similar. The difference being that the uracil moiety is less effective than the cytosine moiety at binding and ordering turns A and B. Nucleotide-free viperin contains a (βα)6 partial barrel and has a disordered N-terminal extension and a partially ordered C-terminal extension. [18] When the C-terminal tail is ordered, a six-residue α-helix, an eight-residue P-loop (that binds the γ-phosphate of CTP), and a 310-helix are revealed.

Cellular localization

Viperin is normally localized to the endoplasmic reticulum (ER) via its N-terminal domain, and also localized to lipid droplet, which are derived from the ER. [15] However, it is also found in mitochondria in the HCMV infected fibroblasts. [10]

Related Research Articles

<span class="mw-page-title-main">Interferon</span> Signaling proteins released by host cells in response to the presence of pathogens

Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.

<span class="mw-page-title-main">Antiviral drug</span> Medication used to treat a viral infection

Antiviral drugs are a class of medication used for treating viral infections. Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. Antiviral drugs are a class of antimicrobials, a larger group which also includes antibiotic, antifungal and antiparasitic drugs, or antiviral drugs based on monoclonal antibodies. Most antivirals are considered relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from virucides, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural virucides are produced by some plants such as eucalyptus and Australian tea trees.

<span class="mw-page-title-main">Hepatitis C virus</span> Species of virus

The hepatitis C virus (HCV) is a small, enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer and lymphomas in humans.

<i>Dengue virus</i> Species of virus

Dengue virus (DENV) is the cause of dengue fever. It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, all of which can cause the full spectrum of disease. Nevertheless, the mainstream scientific community's understanding of dengue virus may be simplistic as, rather than distinct antigenic groups, a continuum appears to exist. This same study identified 47 strains of dengue virus. Additionally, coinfection with and lack of rapid tests for Zika virus and chikungunya complicate matters in real-world infections.

<span class="mw-page-title-main">Nucleoside analogue</span> Biochemical compound

Nucleoside analogues are structural analogues of a nucleoside, which normally contain a nucleobase and a sugar. Nucleotide analogues are analogues of a nucleotide, which normally has one to three phosphates linked to a nucleoside. Both types of compounds can deviate from what they mimick in a number of ways, as changes can be made to any of the constituent parts. They are related to nucleic acid analogues.

<i>Murine respirovirus</i> Sendai virus, virus of rodents

Murine respirovirus, formerly Sendai virus (SeV) and previously also known as murine parainfluenza virus type 1 or hemagglutinating virus of Japan (HVJ), is an enveloped, 150-200 nm–diameter, negative sense, single-stranded RNA virus of the family Paramyxoviridae. It typically infects rodents and it is not pathogenic for humans or domestic animals.

<span class="mw-page-title-main">Interleukin 29</span> Protein-coding gene in the species Homo sapiens

Interleukin-29 (IL-29) is a cytokine and it belongs to type III interferons group, also termed interferons λ (IFN-λ). IL-29 plays an important role in the immune response against pathogenes and especially against viruses by mechanisms similar to type I interferons, but targeting primarily cells of epithelial origin and hepatocytes.

NSP1 (NS53), the product of rotavirus gene 5, is a nonstructural RNA-binding protein that contains a cysteine-rich region and is a component of early replication intermediates. RNA-folding predictions suggest that this region of the NSP1 mRNA can interact with itself, producing a stem-loop structure similar to that found near the 5'-terminus of the NSP1 mRNA.

<span class="mw-page-title-main">ISG15</span> Protein found in humans

Interferon-stimulated gene 15 (ISG15) is a 17 kDa secreted protein that in humans is encoded by the ISG15 gene. ISG15 is induced by type I interferon (IFN) and serves many functions, acting both as an extracellular cytokine and an intracellular protein modifier. The precise functions are diverse and vary among species but include potentiation of Interferon gamma (IFN-II) production in lymphocytes, ubiquitin-like conjugation to newly-synthesized proteins and negative regulation of the IFN-I response.

<span class="mw-page-title-main">IFNA2</span> Mammalian protein found in Homo sapiens

Interferon alpha-2 is a protein that in humans is encoded by the IFNA2 gene.

<span class="mw-page-title-main">Mitochondrial antiviral-signaling protein</span> Protein-coding gene in the species Homo sapiens

Mitochondrial antiviral-signaling protein (MAVS) is a protein that is essential for antiviral innate immunity. MAVS is located in the outer membrane of the mitochondria, peroxisomes, and mitochondrial-associated endoplasmic reticulum membrane (MAM). Upon viral infection, a group of cytosolic proteins will detect the presence of the virus and bind to MAVS, thereby activating MAVS. The activation of MAVS leads the virally infected cell to secrete cytokines. This induces an immune response which kills the host's virally infected cells, resulting in clearance of the virus.

<span class="mw-page-title-main">IFITM1</span> Protein-coding gene in the species Homo sapiens

Interferon-induced transmembrane protein 1 is a protein that in humans is encoded by the IFITM1 gene. IFITM1 has also recently been designated CD225. This protein has several additional names: fragilis, IFI17 [interferon-induced protein 17], 9-27 [Interferon-inducible protein 9-27] and Leu13.

Intrinsic immunity refers to a set of cellular-based anti-viral defense mechanisms, notably genetically encoded proteins which specifically target eukaryotic retroviruses. Unlike adaptive and innate immunity effectors, intrinsic immune proteins are usually expressed at a constant level, allowing a viral infection to be halted quickly. Intrinsic antiviral immunity refers to a form of innate immunity that directly restricts viral replication and assembly, thereby rendering a cell non-permissive to a specific class or species of viruses. Intrinsic immunity is conferred by restriction factors preexisting in certain cell types, although these factors can be further induced by virus infection. Intrinsic viral restriction factors recognize specific viral components, but unlike other pattern recognition receptors that inhibit viral infection indirectly by inducing interferons and other antiviral molecules, intrinsic antiviral factors block viral replication immediately and directly.

<span class="mw-page-title-main">Tetherin</span> Mammalian protein found in Homo sapiens

Tetherin, also known as bone marrow stromal antigen 2, is a lipid raft associated protein that in humans is encoded by the BST2 gene. In addition, tetherin has been designated as CD317. This protein is constitutively expressed in mature B cells, plasma cells and plasmacytoid dendritic cells, and in many other cells, it is only expressed as a response to stimuli from IFN pathway.

<span class="mw-page-title-main">Hepatitis C virus nonstructural protein 5A</span>

Nonstructural protein 5A (NS5A) is a zinc-binding and proline-rich hydrophilic phosphoprotein that plays a key role in Hepatitis C virus RNA replication. It appears to be a dimeric form without trans-membrane helices.

<span class="mw-page-title-main">Antiviral protein</span>

Antiviral proteins are proteins that are induced by human or animal cells to interfere with viral replication. These proteins are isolated to inhibit the virus from replicating in a host's cells and stop it from spreading to other cells. The Pokeweed antiviral protein and the Zinc-Finger antiviral protein are two major antiviral proteins that have undergone several tests for viruses, including HIV and influenza.

RIG-I-like receptors are a type of intracellular pattern recognition receptor involved in the recognition of viruses by the innate immune system. RIG-I is the best characterized receptor within the RIG-I like receptor (RLR) family. Together with MDA5 and LGP2, this family of cytoplasmic pattern recognition receptors (PRRs) are sentinels for intracellular viral RNA that is a product of viral infection. The RLR receptors provide frontline defence against viral infections in most tissues.

Daclatasvir, sold under the brand name Daklinza, is an antiviral medication used in combination with other medications to treat hepatitis C (HCV). The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis. It is taken by mouth.

An interferon-stimulated gene (ISG) is a gene that can be expressed in response to stimulation by interferon. Interferons bind to receptors on the surface of a cell, initiating protein signaling pathways within the cell. This interaction leads to the expression of a subset of genes involved in the innate immune system response. ISGs are commonly expressed in response to viral infection, but also during bacterial infection and in the presence of parasites. It's currently estimated that 10% of the human genome is regulated by interferons (IFNs). Interferon stimulated genes can act as an initial response to pathogen invasion, slowing down viral replication and increasing expression of immune signaling complexes. There are three known types of interferon. With approximately 450 genes highly expressed in response to interferon type I. Type I interferon consists of INF-α, INF-β, INF-ω and is expressed in response to viral infection. ISGs induced by type I interferon are associated with viral replication suppression and increase expression of immune signaling proteins. Type II interferon consists only of INF-γ and is associated with controlling intracellular pathogens and tumor suppressor genes. Type III interferon consists of INF-λ and is associated with viral immune response and is key in anti-fungal neutrophil response.

<span class="mw-page-title-main">NS5B inhibitor</span> Class of pharmaceutical drugs

Non-structural protein 5B (NS5B) inhibitors are a class of direct-acting antivirals widely used in the treatment of chronic hepatitis C. Depending on site of action and chemical composition, NS5B inhibitors may be categorized into three classes—nucleoside active site inhibitors (NIs), non-nucleoside allosteric inhibitors, and pyrophosphate analogues. Subsequently, all three classes are then subclassified. All inhibit RNA synthesis by NS5B but at different stages/sites resulting in inability of viral RNA replication. Expression of direct-acting NS5B inhibitors does not take place in cells that are not infected by hepatitis C virus, which seems to be beneficial for this class of drugs.

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000134321 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000020641 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Seo JY, Yaneva R, Cresswell P (December 2011). "Viperin: a multifunctional, interferon-inducible protein that regulates virus replication". Cell Host & Microbe. 10 (6): 534–9. doi:10.1016/j.chom.2011.11.004. PMC   3246677 . PMID   22177558.
  6. 1 2 Mattijssen S, Pruijn GJ (May 2012). "Viperin, a key player in the antiviral response". Microbes and Infection. 14 (5): 419–26. doi: 10.1016/j.micinf.2011.11.015 . hdl: 2066/94161 . PMID   22182524.
  7. ↑ Helbig KJ, Beard MR (March 2014). "The role of viperin in the innate antiviral response". Journal of Molecular Biology. Antiviral Innate Immunity (Part II). 426 (6): 1210–9. doi: 10.1016/j.jmb.2013.10.019 . hdl: 2440/94032 . PMID   24157441.
  8. 1 2 Ji Y, Wei L, Da A, Stark H, Hagedoorn PL, Ciofi-Baffoni S, et al. (21 October 2022). "Radical-SAM dependent nucleotide dehydratase (SAND), rectification of the names of an ancient iron-sulfur enzyme using NC-IUBMB recommendations". Frontiers in Molecular Biosciences. 9: 1032220. doi: 10.3389/fmolb.2022.1032220 . PMC   9642334 . PMID   36387278.
  9. ↑ Chin KC, Cresswell P (December 2001). "Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus". Proceedings of the National Academy of Sciences of the United States of America. 98 (26): 15125–15130. Bibcode:2001PNAS...9815125C. doi: 10.1073/pnas.011593298 . PMC   64994 . PMID   11752458.
  10. 1 2 3 Seo JY, Yaneva R, Hinson ER, Cresswell P (May 2011). "Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity". Science. 332 (6033): 1093–1097. Bibcode:2011Sci...332.1093S. doi: 10.1126/science.1202007 . PMID   21527675. S2CID   22293459.
  11. ↑ Gizzi AS, Grove TL, Arnold JJ, Jose J, Jangra RK, Garforth SJ, et al. (June 2018). "A naturally occurring antiviral ribonucleotide encoded by the human genome". Nature. 558 (7711). Springer Science and Business Media LLC: 610–614. Bibcode:2018Natur.558..610G. doi:10.1038/s41586-018-0238-4. PMC   6026066 . PMID   29925952.
  12. ↑ Honarmand Ebrahimi K, Vowles J, Browne C, McCullagh J, James WS (May 2020). "ddhCTP produced by the radical-SAM activity of RSAD2 (viperin) inhibits the NAD+ -dependent activity of enzymes to modulate metabolism". FEBS Letters. 594 (10): 1631–1644. doi: 10.1002/1873-3468.13778 . PMID   32232843.
  13. ↑ Wang X, Hinson ER, Cresswell P (August 2007). "The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts". Cell Host & Microbe. 2 (2): 96–105. doi: 10.1016/j.chom.2007.06.009 . PMID   18005724.
  14. ↑ Helbig KJ, Eyre NS, Yip E, Narayana S, Li K, Fiches G, et al. (November 2011). "The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A". Hepatology. 54 (5): 1506–1517. doi:10.1002/hep.24542. PMC   3207276 . PMID   22045669.
  15. 1 2 Hinson ER, Cresswell P (December 2009). "The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix". Proceedings of the National Academy of Sciences of the United States of America. 106 (48): 20452–20457. Bibcode:2009PNAS..10620452H. doi: 10.1073/pnas.0911679106 . PMC   2778571 . PMID   19920176.
  16. ↑ Jiang D, Guo H, Xu C, Chang J, Gu B, Wang L, et al. (February 2008). "Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus". Journal of Virology. 82 (4): 1665–1678. doi:10.1128/JVI.02113-07. PMC   2258705 . PMID   18077728.
  17. ↑ Fenwick MK, Su D, Dong M, Lin H, Ealick SE (February 2020). "Structural Basis of the Substrate Selectivity of Viperin". Biochemistry. 59 (5). American Chemical Society (ACS): 652–662. doi:10.1021/acs.biochem.9b00741. PMC   7920147 . PMID   31917549.
  18. ↑ Fenwick MK, Li Y, Cresswell P, Modis Y, Ealick SE (June 2017). "Structural studies of viperin, an antiviral radical SAM enzyme". Proceedings of the National Academy of Sciences of the United States of America. 114 (26). Proceedings of the National Academy of Sciences: 6806–6811. Bibcode:2017PNAS..114.6806F. doi: 10.1073/pnas.1705402114 . PMC   5495270 . PMID   28607080.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.